29. Murray, R. “Viral Hepatitis.” Bulletin of the New York Academy of Medicine 31 (1955): 341–58.
30. Hamilton, V. “Follow-Up on Shellfish-Associated Hepatitis: Southern United States.” MMWR Morbidity and Mortality Weekly Report 22 (1973): 388.
31. Ruddy, S. J., R. F. Johnson, J. W. Mosley, J. B. Atwater, M. A. Rossetti, and J. C. Hart. “An Epidemic of Clam-Associated Hepatitis.” Journal of the American Medical Association 208 (1969): 649–55.
32. Amon, J. J., R. Devasia, G. Xia, O. V. Nainan, S. Hall, B. Lawson, J. S. Wolthuis, et al. “Molecular Epidemiology of Foodborne Hepatitis A Outbreaks in the United States, 2003.” Journal of Infectious Diseases 192 (2005): 1323–30.
33. Schilling, D. R. “Adult Oysters Filter Fifty Gallons of Water Per Day.” Industry Tap, June 23, 2015. www.industrytap.com/ adult– oysters– filterfiftygallons– water– day// 28760.
34. Feinstone, S. M., A. Z. Kapikian, and R. H. Purcell. “Hepatitis A: Detection by Immune Electron Microscopy of a Virus-Like Antigen Associated with Acute Illness.” Science 182 (1973): 1026–28.
35. Sisson, P. “Two Years After It Started, San Diego Declares End to Deadly Hepatitis A Outbreak.” San Diego Union Tribune, October 30, 2018.
36. November 15, 2018. https://www.sandiegocounty.gov/content/sdc/hhsa/programs/phs/community_epidemiolo.
37. Portnoy, B. L., P. A. Mackowiak, C. T. Caraway, J. A. Walker, T. W. McKinley, and C. A. Klein, Jr. “Oyster-Associated Hepatitis. Failure of Shellfish Certification Programs to Prevent Outbreaks.” Journal of the American Medical Association 233 (1975): 1065–68.
38. Pinto, R. M., M. I. Costafreda, and A. Bosch. “Risk Assessment in Shellfish-Borne Outbreaks of Hepatitis A.” Applied and Environmental Microbiology 75 (2009): 7350–55.
39. US Food and Drug Administration. “FDA Investigates Outbreak of Hepatitis A Illnesses Linked to Raw Scallops.” August 24, 2016. https://www.fda.gov/Food/RecallsOutbreaksEmergencies/Outbreaks/ucm517289.htm.
40. Alter, H. J. “The Road Not Taken or How I Learned to Love the Liver: A Personal Perspective on Hepatitis History.” Hepatology 59 (2014): 4–12.
41. Alter, H. J., and H. G. Klein. “The Hazards of Blood Transfusion in Historical Perspective.” Blood 112 (2008): 2617–26.
42. “City Blood Program Is Termed Chaotic.” New York Journal-American, May 3, 1963.
43. Blumberg, B. S., H. J. Alter, and S. A. Visnich. “A New Antigen in Leukemia Sera.” Journal of the American Medical Association 191 (1965): 541–46.
44. Alter, H. S., and B. S. Blumberg. “Further Studies on a ‘New’ Human Isoprecipitin System (Australia Antigen).” Blood 27 (1966): 297–309.
45. Blumberg, B. S. “Polymorphism of Serum Proteins for Different Populations: Australia Antigen Blood Proteins.” Nobel Prize in Medicine and Physiology, 1976.
46. Alter, H. S. “Baruch Blumberg.” Nature 473 (2011): 155.
47. Sutnick, A. I., W. T. London, B. J. S. Gerstley, M. M. Cronlund, and B. S. Blumberg. “Anicteric Hepatitis Associated with Australia Antigen. Occurrence in Patients with Down’s Syndrome.” Journal of the American Medical Association 205 (1968): 670–74.
48. Prince, A. M. “An Antigen Detected in Blood During Incubation Period of Serum Hepatitis.” Proceedings of the National Academy of Sciences USA 60 (1968): 814–21.
49. London, W. T., A. I. Sutnick, and B. S. Blumberg. “Australia Antigen and Acute Viral Hepatitis.” Annals of Internal Medicine 70 (1969): 55–59.
50. Prince, A. M., R. L. Hargrove, W. Szmuness, C. E. Cherubin, V. J. Fontana, and M. B. Jeffries. “Immunologic Distinction Between Infectious and Serum Hepatitis.” New England Journal of Medicine 282 (1970): 282–87.
51. Walsh, J. H., R. H. Purcell, A. G. Morrow, R. M. Chanock, and P. J. Schmidt. “Posttransfusion Hepatitis after Open-Heart Operations. Incidence after the Administration of Blood from Commercial and Volunteer Donor Populations.” Journal of the American Medical Association 211 (1970): 261–65.
52. Alter, H. J., P. V. Holland, R. H. Purcell, J. J. Lander, S. M. Feinstone, A. G. Morrow, and P. J. Schmidt. “Posttransfusion Hepatitis after Exclusion of the Commercial and Hepatitis B Antigen Positive Donor.” Annals of Internal Medicine 77 (1972): 691–99.
53. Feinstone, S. M., A. Z. Kapikian, R. H. Purcell, H. J. Alter, and P. V. Holland. “Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B.” New England Journal of Medicine 292 (1975): 767–70.
54. Alter, H. J., R. H. Purcell, P. V. Holland, and H. Popper. “Transmissible Agent in ‘Non-A, Non-B’ Hepatitis.” Lancet 1 (1978): 463–65.
55. Tabor, E., R. J. Gerety, J. A. Drucker, L. B. Seeff, J. H. Hoofnagle, D. R. Jackson, M. April, L. F. Barker, and G. Pineda-Tamondong. “Transmission of Non-A, Non-B Hepatitis from Man to Chimpanzee.” Lancet 1 (1978): 466–68.
56. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. “Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome.” Science 244 (1989): 359–62.
57. Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari. “Robust Hepatitis C Virus Infection In Vitro.” Proceedings of the National Academy of Sciences USA 102 (2005): 9294–99.
58. Lindenbach, B. D., M. J. Evans, A. J. Syder, B. Wolk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, et al. “Complete Replication of Hepatitis C Virus in Cell Culture.” Science 309 (2005): 623–26.
59. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, et al. “Production of Infectious Hepatitis C Virus in Tissue Culture from a Cloned Viral Genome.” Nature Medicine 11 (2005): 791–96.
60. Shlomai, A., and C. M. Rice. “Getting Rid of a Persistent Troublemaker to Cure Hepatitis.” Science 343 (2014): 1212–13.
Глава 9. Общий обзор только что появившихся вирусных эпидемий: геморрагических лихорадок. Новый таинственный вирусный подозреваемый – острый вялотекущий паралич
1. LeGuenno, B. “Emerging Viruses.” Scientific American 273 (October 1995): 56–64.
2. McNeill, W. H. Plagues and Peoples. New York: Anchor Books, 1976.
3. Riviere, Y., and M. B. A. Oldstone. “Genetic Reassortants of Lymphocytic Choriomeningitis Virus: Unexpected Disease and Mechanism of Pathogenesis.” Journal of Virology 59 (1986): 363–68.
4. Oldstone, M. B. A., M. Salvato, A. Tishon, and H. Lewicki. “Virus – Lymphocyte Interactions. III. Biologic Parameters of a Virus Variant That Fails to Generate CTL and Establishes Persistent Infection in Immunocompetent hosts.” Virology 164 (1988): 507–16.
